MedTrace Logo

Extracorporal Shock Wave Treatment to Improve Nerve Regeneration

NCT03147313 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-09-05

No results posted yet for this study

Summary

This study evaluates the impact of extracorporeal shock wave treatment after microsurgical coaptation of finger nerves. Participants will be randomized into two treatment groups with different settings and a sham group. The participants will thereafter followed-up in a prospective, double-blind study design.

Conditions

  • Peripheral Nerve Injury

Interventions

DEVICE

MTS Medical UG Orthogold 100

300 or 500 pulses, frequency 3Hz, energy 1 (0,1mJ/mm2)

DEVICE

Sham

Extracorporeal shock wave treatment will be faked.

Sponsors & Collaborators

  • Ludwig Boltzmann Gesellschaft

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-18
Primary Completion
2023-04-30
Completion
2023-06-30

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03147313 on ClinicalTrials.gov